BRUKER CORP is 8.0x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($8.24 B vs $1.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EYPT | BRKR |
|---|---|---|
| Market cap | $1.03 B | $8.24 B |
| US-listed rank | #2607 | #1057 |
| Revenue (latest FY) | $31.37M | $3.44B |
| Net income (latest FY) | -$231.96M | -$8.30M |
| Net margin | -739.4% | -0.2% |
| SEC filings | 1,308 | 1,361 |
BRUKER CORP is 8.0x more valuable than EyePoint Pharmaceuticals, Inc. by market capitalization ($8.24 B vs $1.03 B).
In their latest fiscal years, EyePoint Pharmaceuticals, Inc. reported $31.37M in revenue while BRUKER CORP reported $3.44B.
Full pages: EyePoint Pharmaceuticals, Inc. and BRUKER CORP, or browse the full rankings.